Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Assembly Biosciences stock | 5.62

Own Assembly Biosciences stock in just a few minutes.

Posted

Fact checked

Assembly Biosciences, Inc is a biotechnology business based in the US. Assembly Biosciences shares (ASMB) are listed on the NASDAQ and all prices are listed in US Dollars. Assembly Biosciences employs 139 staff and has a trailing 12-month revenue of around USD$52.5 million.

How to buy shares in Assembly Biosciences

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Assembly Biosciences. Find the stock by name or ticker symbol: ASMB. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Assembly Biosciences reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$5.62, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Assembly Biosciences, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Assembly Biosciences. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Assembly Biosciences's share price?

Since the stock market crash in March caused by coronavirus, Assembly Biosciences's share price has had significant negative movement.

Its last market close was USD$5.62, which is 73.53% down on its pre-crash value of USD$21.23 and 82.03% down on the lowest point reached during the March crash when the shares fell as low as USD$10.23.

If you had bought USD$1,000 worth of Assembly Biosciences shares at the start of February 2020, those shares would have been worth USD$798.53 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$306.12.

Assembly Biosciences share price

Use our graph to track the performance of ASMB stocks over time.

Assembly Biosciences shares at a glance

Information last updated 2020-10-20.
Latest market close USD$5.62
52-week range USD$10.23 - USD$25.78
50-day moving average USD$17.0646
200-day moving average USD$19.8907
Wall St. target price USD$43
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-3.664

Buy Assembly Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Assembly Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Assembly Biosciences price performance over time

Historical closes compared with the close of $5.62 from 2020-11-16

1 week (2020-11-17) 0.18%
1 month (2020-10-23) -62.21%
3 months (2020-08-25) -73.86%
6 months (2020-05-23) N/A
1 year (2019-11-25) -62.73%
2 years (2018-11-23) -77.78%
3 years (2017-11-24) -86.97%
5 years (2015-11-25) -42.06%

Assembly Biosciences financials

Revenue TTM USD$52.5 million
Gross profit TTM USD$-69,794,000
Return on assets TTM -17.27%
Return on equity TTM -32.35%
Profit margin -136.24%
Book value $8.142
Market capitalisation USD$510.9 million

TTM: trailing 12 months

Shorting Assembly Biosciences shares

There are currently 3.9 million Assembly Biosciences shares held short by investors – that's known as Assembly Biosciences's "short interest". This figure is 4.3% up from 3.7 million last month.

There are a few different ways that this level of interest in shorting Assembly Biosciences shares can be evaluated.

Assembly Biosciences's "short interest ratio" (SIR)

Assembly Biosciences's "short interest ratio" (SIR) is the quantity of Assembly Biosciences shares currently shorted divided by the average quantity of Assembly Biosciences shares traded daily (recently around 294362.71963331). Assembly Biosciences's SIR currently stands at 13.09. In other words for every 100,000 Assembly Biosciences shares traded daily on the market, roughly 13090 shares are currently held short.

However Assembly Biosciences's short interest can also be evaluated against the total number of Assembly Biosciences shares, or, against the total number of tradable Assembly Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Assembly Biosciences's short interest could be expressed as 0.12% of the outstanding shares (for every 100,000 Assembly Biosciences shares in existence, roughly 120 shares are currently held short) or 0.1213% of the tradable shares (for every 100,000 tradable Assembly Biosciences shares, roughly 121 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Assembly Biosciences.

Find out more about how you can short Assembly Biosciences stock.

Assembly Biosciences share dividends

We're not expecting Assembly Biosciences to pay a dividend over the next 12 months.

Have Assembly Biosciences's shares ever split?

Assembly Biosciences's shares were split on a 1:5 basis on 14 July 2014. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Assembly Biosciences shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Assembly Biosciences shares which in turn could have impacted Assembly Biosciences's share price.

Assembly Biosciences share price volatility

Over the last 12 months, Assembly Biosciences's shares have ranged in value from as little as $10.23 up to $25.78. A popular way to gauge a stock's volatility is its "beta".

ASMB.US volatility(beta: 1.2)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Assembly Biosciences's is 1.203. This would suggest that Assembly Biosciences's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Assembly Biosciences overview

Assembly Biosciences, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutic candidates to treat disorders associated with the microbiome. It is involved in the development of core inhibitors that inhibit the functional activities of HBV core protein at various points in the viral lifecycle. The company's microbiome program consists of an integrated platform that includes the disease-targeted strain isolation, identification, characterization, and selection process for strain purification and growth under current good manufacturing practice conditions; and a licensed patented delivery system, GEMICEL, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal tract. Its product candidates include ABI-H0731 that is in Phase 2a clinical trials for the treatment of HBV; ABI-H2158, which is in Phase 1a/1b dose-ranging clinical study in the HBV-cure program; and ABI-H3733 that is in preclinical studies for the treatment of HBV. In addition, the company engages in the development of product candidates for various disease indications, such as Crohn's disease, irritable bowel syndrome, immune-mediated and metabolic disorders, and oncology by using its microbiome platform. It has a collaboration agreement with Allergan Pharmaceuticals International Limited for the development and commercialization of various microbiome gastrointestinal programs. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in South San Francisco, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site